A review on photobiomodulation therapy for olfactory dysfunction caused by COVID-19
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Olfactory dysfunction is a loss of smell caused by a number of conditions such as chronic rhinosinusitis, neurodegenerative disease, aging, and viral infection, and it is a common symptom Coronavirus Disease 2019 (COVID-19). Photobiomodulation (PBM) is a non-invasive, safe, and effective treatment for a range of disorders. It has an anti-inflammatory action and stimulates tissue healing, which can help with the reversal of olfactory dysfunction. Due to the limited options for immunocom-promised patients, there is currently a need for an alternative treatment method for olfactory dysfunction. This review highlights the most recent research on the use of PBM for the treatment of olfactory dysfunction.
Abstract
Olfactory dysfunction is a loss of smell caused by a number of conditions such as chronic rhinosinusitis, neurodegenerative disease, aging, and viral infection, and it is a common symptom Coronavirus Disease 2019 (COVID-19). Photobiomodulation (PBM) is a non-invasive, safe, and effective treatment for a range of disorders. It has an anti-inflammatory action and stimulates tissue healing, which can help with the reversal of olfactory dysfunction. Due to the limited options for immunocom-promised patients, there is currently a need for an alternative treatment method for olfactory dysfunction. This review highlights the most recent research on the use of PBM for the treatment of olfactory dysfunction.
참고문헌 (47)
- Cramer CK, "Olfaction and apathy in Parkinson's disease", Parkinsonism Relat Disord, 16, pp.124~126 (2010)
- Hummel T, "Smell and taste disorders", GMS Curr Top Otorhinolaryngol Head Neck Surg, 10, pp.Doc04~ (2011)
- Claes G, "Case report : olfactory loss and unrelated chronic rhinosinusitis", B-ENT, 3, pp.101~104 (2007)
- Najafloo R, "Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments", ACS Chem Neurosci, 12, pp.3795~3805 (2021)
- Fodoulian L, "SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain", iScience, 23, pp.101839~ (2020)
- Li W, "COVID-19, cilia, and smell", FEBS J, 287, pp.3672~3676 (2020)
- Brann DH, "Non-neuronal expression of SARS-CoV-2entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia", Sci Adv, 6, pp.eabc5801~ (2020)
- Lechien JR, "Olfactory and gustatory dys functions as a clinical presentation of mild-to-moderate forms of the coronavirus disease(COVID-19) : a multicenter European study", Eur Arch Otorhinolaryngol, 277, pp.2251~2261 (2020)
- Whitcroft KL, "Olfactory dysfunction in COVID-19 : diagnosis and management", JAMA, 323, pp.2512~2514 (2020)
- Mott AE, "Topical corticosteroid treatment of anosmia associated with nasal and sinus disease", Arch Otolaryngol Head Neck Surg, 123, pp.367~372 (1997)
- Abdelalim AA, "Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients : a randomized controlled trial", Am J Otolaryngol, 42, pp.102884~ (2021)
- Stenner M, "Topical therapy in anosmia : relevance of steroid-responsiveness", Laryngoscope, 118, pp.1681~1686 (2008)
- Russell CD, "Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury", Lancet, 395, pp.473~475 (2020)
- Grzanka A, "Molecular mechanisms of glucocorticoids action : implications for treatment of rhinosinusitis and nasal polyposis", Eur Arch Otorhinolaryngol, 268, pp.247~253 (2011)
- Lu S, "Effectiveness and safety of glucocorticoids to treat COVID-19 : a rapid review and meta-analysis", Ann Transl Med, 8, pp.627~ (2020)
- Whitcroft KL, "The effect of intranasal sodium citrate on olfaction in post-infectious loss : results from a prospective, placebo-controlled trial in 49 patients", Clin Otolaryngol, 42, pp.557~563 (2017)
- Jafari A, "Therapies for olfactory dysfunction-an update", Curr Allergy Asthma Rep, 22, pp.21~28 (2022)
- Yan CH, "Effect of omega-3 supplementation in patients with smell dysfunction following endoscopic sellar and parasellar tumor resection : a multicenter prospective randomized controlled trial", Neurosurgery, 87, pp.E91~E98 (2020)
- Hummel T, "Intranasal vitamin A is beneficial in post-infectious olfactory loss", Eur Arch Otorhinolaryngol, 274, pp.2819~2825 (2017)
- de Freitas LF, "Proposed mechanisms of photobiomodulation or low-level light therapy", IEEE J Sel Top Quantum Electron, 22, pp.7000417~ (2016)
- Ray PD, "Reactive oxygen species(ROS)homeostasis and redox regulation in cellular signaling", Cell Signal, 24, pp.981~990 (2012)
- Khan I, "Accelerated burn wound healing with photobiomodulation therapy involves activation of endogenous latent TGF-β1", Sci Rep, 11, pp.13371~ (2021)
- Leyane TS, "Cellular signalling and photobiomodulation in chronic wound repair", Int J Mol Sci, 22, pp.11223~ (2021)
- Wang ZX, "Effect of photobiomodulation therapy(660 nm)on wound healing of rat skin infected by Staphylococcus", Photobiomodul Photomed Laser Surg, 38, pp.419~424 (2020)
- Pavlov SB, "Experimental study of the effect of photobiomodulation therapy on the regulation of the healing process of chronic wounds", Int J Photoenergy, 2021, pp.3947895~ (2021)
- Bjordal JM, "A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations", Br J Sports Med, 40, pp.76~80 (2006)
- Pallotta RC, "Infrared(810-nm)low-level laser therapy on rat experimental knee inflammation", Lasers Med Sci, 27, pp.71~78 (2012)
- Aimbire F, "Low-level laser therapy induces dose-dependent reduction of TNFalpha levels in acute inflammation", Photomed Laser Surg, 24, pp.33~37 (2006)
- Hamblin MR, "Mechanisms and applications of the antiinflammatory effects of photobiomodulation", AIMS Biophys, 4, pp.337~361 (2017)
- Rosso MPO, "Photobiomodulation therapy(PBMT)in peripheral nerve regeneration : a systematic review", Bioengineering(Basel), 5, pp.44~ (2018)
- Hanna R, "Role of photobiomodulation therapy in neurological primary burning mouth syndrome. A systematic review and meta-analysis of human randomised controlled clinical trials", Pharmaceutics, 13, pp.1838~ (2021)
- Maksimovich IV, "Intracerebral transcatheter laser photobiomodulation therapy in the treatment of Binswanger's disease and vascular parkinsonism : research and clinical experience", Photobiomodul Photomed Laser Surg, 37, pp.606~614 (2019)
- Hamblin MR, "Photobiomodulation for traumatic brain injury and stroke", J Neurosci Res, 96, pp.731~743 (2018)
- Iglesias-Rey R, "New strategies for ischemic stroke : internal photobiomodulation therapy", Neural Regen Res, 15, pp.1658~1659 (2020)
- Argibay B, "Light-emitting diode photobiomodulation after cerebral ischemia", Front Neurol, 10, pp.911~ (2019)
- Yang M, "Current application and future directions of photobiomodulation in central nervous diseases", Neural Regen Res, 16, pp.1177~1185 (2021)
- Souza NHC, "Photobiomodulation and different macrophages phenotypes during muscle tissue repair", J Cell Mol Med, 22, pp.4922~4934 (2018)
- Ferraresi C, "Photobiomodulation in human muscle tissue : an advantage in sports performance?", J Biophotonics, 9, pp.1273~1299 (2016)
- Lee SY, "Enhancement of cutaneous immune response to bacterial infection after low-level light therapy with 1072 nm infrared light : a preliminary study", J Photochem Photobiol B, 105, pp.175~182 (2011)
- Salehpour F, "Brain photobiomodulation therapy : a narrative review", Mol Neurobiol, 55, pp.6601~6636 (2018)
- Croen KD, "Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication", J Clin Invest, 91, pp.2446~2452 (1993)
- Karupiah G, "Inhibition of viral replication by interferon-gammainduced nitric oxide synthase", Science, 261, pp.1445~1448 (1993)
- Hamblin MR, "Shining light on the head : photobiomodulation for brain disorders", BBA Clin, 6, pp.113~124 (2016)
- Skobelkin OK, "Preoperative activation of the immune system by low reactive level laser therapy(LLLT)in oncologic patients : a preliminary report", Laser Ther, 3, pp.169~175 (1991)
- Hamblin MR, "Proceedings Volume 6846, Mechanisms for Low-Light Therapy III" (2008), SPIE
- de Souza VB, "Photobiomodulation therapy for treatment olfactory and taste dysfunction COVID-19-related: a case report", J Biophotonics (2022)
- Soares LES, "Intranasal photobiomodulation therapy for COVID-19-related olfactory dysfunction : a Brazilian multicenter case series", Photodiagnosis Photodyn Ther, 36, pp.102574~ (2021)
